Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J HAVEL

Showing results (11-20 of 199) with videos related to

Pageof 20
Sort By:
Drugs|January 1, 1994
Analysis of angiographic trial data in womenR J Havel
Current Opinion in Lipidology|October 1, 1995
Chylomicron remnants: hepatic receptors and metabolismR J Havel
Circulation|October 23, 1997
Benefits of fibrate drugs in coronary heart disease patients with normal cholesterol levelsR J Havel
Advances in Experimental Medicine and Biology|January 1, 1975
Lipoproteins and lipid transportR J Havel
The New England Journal of Medicine|September 2, 1971
The abnormal lipoprotein of cholestasisR J Havel
Atherosclerosis|January 15, 1999
Receptor and non-receptor mediated uptake of chylomicron remnants by the liverR J Havel
The American Journal of Clinical Nutrition|June 6, 2000
Genetic underpinnings of LDL size and density: a role for hepatic lipase?R J Havel
Agents and Actions. Supplements|January 1, 1988
Role of the liver in reverse cholesterol transportR J Havel
Atherosclerosis|January 1, 1970
Typing of hyperlipoproteinemiasR J Havel
Arteriosclerosis (Dallas, Tex.)|November 1, 1985
George Lyman Duff memorial lecture. Role of the liver in atherosclerosisR J Havel
Pageof 20

Showing results (11-20 of 199) with videos related to

Sort By:
Pageof 20
Drugs|January 1, 1994
Analysis of angiographic trial data in womenR J Havel
Current Opinion in Lipidology|October 1, 1995
Chylomicron remnants: hepatic receptors and metabolismR J Havel
Circulation|October 23, 1997
Benefits of fibrate drugs in coronary heart disease patients with normal cholesterol levelsR J Havel
Advances in Experimental Medicine and Biology|January 1, 1975
Lipoproteins and lipid transportR J Havel
The New England Journal of Medicine|September 2, 1971
The abnormal lipoprotein of cholestasisR J Havel
Atherosclerosis|January 15, 1999
Receptor and non-receptor mediated uptake of chylomicron remnants by the liverR J Havel
The American Journal of Clinical Nutrition|June 6, 2000
Genetic underpinnings of LDL size and density: a role for hepatic lipase?R J Havel
Agents and Actions. Supplements|January 1, 1988
Role of the liver in reverse cholesterol transportR J Havel
Atherosclerosis|January 1, 1970
Typing of hyperlipoproteinemiasR J Havel
Arteriosclerosis (Dallas, Tex.)|November 1, 1985
George Lyman Duff memorial lecture. Role of the liver in atherosclerosisR J Havel
Pageof 20